Liposomal bupivacaine was launched on the market twelve years ago to provide long-lasting local control of pain.
Novavax seeks EMA approval for updated JN.1 Covid-19 vaccine
NVX-CoV2705 is a modified formulation of the original Covid-19 vaccine. Credit: benjamin poturak / Shutterstock. Novavax has submitted a type II variation application with the